ArticleBMC infectious diseases2026
COVID-19 status and intensive care unit burden and mortality: a single-center retrospective cohort study comparing COVID-19 and non-COVID-19 admissions.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCoronavirus disease 2019 (COVID-19) placed substantial pressure on intensive care units (ICUs), but long-period comparisons with non-COVID-19 ICU patients remain useful for distinguishing disease-associated patterns from the general burden of critical illness. We addressed the gap in single-center data linking COVID-19 status with mortality, healthcare-associated infections, admission physiology, and Therapeutic Intervention Scoring System-28 (TISS-28) workload in a mixed tertiary ICU.
methodsThis single-center retrospective cohort study included first admissions to the adult ICU of the University Clinical Hospital in Białystok, Poland, between January 1, 2017, and June 1, 2023. Patients were classified as COVID-19-positive (n = 355) or COVID-19-negative (n = 2971) according to reverse transcription-polymerase chain reaction testing. Baseline characteristics, comorbidities, healthcare-associated infections, admission laboratory and arterial blood gas variables, and TISS-28 variables were compared using Welch t-tests, chi-square tests, or Fisher exact tests, as appropriate. Effect sizes are reported with 95% confidence intervals. Logistic regression estimated the association between COVID-19 status and in-hospital mortality in unadjusted, baseline-adjusted, and exploratory complete-case models.
resultsIn-hospital mortality was higher in COVID-19-positive patients than in COVID-19-negative patients (227/355 [63.9%] vs. 1320/2971 [44.4%]; odds ratio [OR] 2.22, 95% CI 1.77 to 2.79). This association remained after baseline adjustment (adjusted OR 2.03, 95% CI 1.60 to 2.58) and in the exploratory complete-case model including admission physiology and laboratory markers (adjusted OR 2.73, 95% CI 1.60 to 4.64). Among non-survivors, time to death was shorter in the COVID-19-positive group (10.7 [SD 7.4] vs. 14.3 [SD 20.0] days; mean difference - 3.63 days, 95% CI -5.07 to -2.18). Bacterial bloodstream infection was more frequent in COVID-19-positive patients (22.8% vs. 9.9%; OR 2.70, 95% CI 2.05 to 3.56). At admission, COVID-19-positive patients had lower C-reactive protein, procalcitonin, PaO2, creatinine, and lactate, but higher PaCO2, glucose, sodium, potassium, bicarbonate, and hemoglobin values. TISS-28 profiles differed by COVID-19 status, most notably for respiratory physiotherapy recorded at least once (97.5% vs. 62.0%; OR 23.63, 95% CI 11.76 to 47.52) and longer duration of respiratory physiotherapy (mean difference 4.89 days, 95% CI 3.57 to 6.22).
conclusionsIn this retrospective cohort, COVID-19-positive status was associated with higher in-hospital mortality, shorter time to death among non-survivors, more frequent bacterial bloodstream infection, and a distinct ICU workload profile. These findings should be interpreted as associations rather than causal effects because of the single-center design, long heterogeneous study period, incomplete severity-score data, and lack of shift-level staffing and high-dependency-unit data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.